Results of Turkish smoking cessation polyclinics data's analysis (TUSPA study)

dc.authorid0000-0001-6842-0587en_US
dc.authorid0000-0002-5180-9649en_US
dc.contributor.authorÖzlü, Tevfik
dc.contributor.authorÖztuna, Funda
dc.contributor.authorEr, Mükremin
dc.contributor.authorAydın, Leyla Yılmaz
dc.contributor.authorUysal, Atilla
dc.contributor.authorŞengezer, Tijen
dc.contributor.authorÇetinkaya, Pelin Duru
dc.contributor.authorSarıoğlu, Nurhan
dc.date.accessioned2019-10-17T07:21:06Z
dc.date.available2019-10-17T07:21:06Z
dc.date.issued2015en_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractAim: The aim of this multicentric, retrospective study is to establish smoking cessation success and the factors associated with these in Turkey. Methods: This study was attended by 26 Smoking Cessation Polyclinics from different regions of Turkey and received 4497 patients (2748 male and 1749 female), retrospectively. Results: The reason of patient's initiation of smoking was inclination to imitate in 45.2% cases. Smoking Cessation Polyclinics' patients were predominantly university graduated (56.3%), high-very high nicotine dependent (56.5%), income-generating employed (67.2%), with comorbid disease (66.9%). Ratio of patients, who have adherence to planned polyclinics visit was 36.2%. The ratio of patients, who had received pharmacotherapy was 56.8%. High education level was 58.6 %, level of high-very high nicotine dependence was 59.1 %, ratio of regular control was 56.1%, ratio of pharmacotherapy was 74.6%, ratio of had income-generating employment was 71%.1 in trying to quit groups (p<0.005). The success rates in patients at the end of the first month, third, sixth and twelfth were 53.5%, 43.3%, 37.4% and %31.3 respectively. Success rates were not different between men and women (Log Rank p=0.187). We observed that appearance of nicotine withdrawal symptoms, existing comorbid diseases and high level of nicotine dependence were independent risk factors for restart smoking. Also, advanced age, pharmacotherapy use, environmental support and regular control were independent risk factors for smoke free time. Conclusions: Highly dependent patients is a risk groups for restart smoking, therefor pharmacotherapy should be carefully planned and followed up.en_US
dc.description.sponsorshipSarıoğlu, Nurhan (Balikesir Author)en_US
dc.identifier.doi10.1183/13993003.congress-2015.PA5126
dc.identifier.issn0903-1936
dc.identifier.issue59en_US
dc.identifier.urihttps://doi.org/10.1183/13993003.congress-2015.PA5126
dc.identifier.uri1399-3003
dc.identifier.urihttps://hdl.handle.net/20.500.12462/7610
dc.identifier.volume46en_US
dc.identifier.wosWOS:000451979407230
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherEuropean Respiratory Soc Journals Ltden_US
dc.relation.ispartofEuropean Respiratory Journalen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectSmokingen_US
dc.subjectTreatmentsen_US
dc.subjectPublic Healthen_US
dc.titleResults of Turkish smoking cessation polyclinics data's analysis (TUSPA study)en_US
dc.typeOtheren_US

Dosyalar

Lisans paketi

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: